MDACC Study No:2006-0679 ( NCT No: NCT00891618)
Title:Acupuncture for chemo-induced peripheral neuropathy in multiple myeloma and lymphoma patients
Principal Investigator:Michael Wang
Treatment Agent:Acupuncture
Study Status:Terminated
Study Description:The goal of this clinical research study is to learn if giving acupuncture to
patients with lymphoma or a plasma cell dyscrasia can help to relieve numbness
and/or tingling of the feet and/or hands that is related to chemotherapy.
Hide details for General InformationGeneral Information

Disease Group:Lymphoma; Myeloma
Phase of Study:Phase II
Treatment Agents:Acupuncture
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:n/a
Supported By:Millennium Pharmaceuticals, Inc
Return Visit:Patients must come to MDACC 3 times per week for 4 weeks, skip one week, then 2
times per week for 4 weeks, then for the one-month follow-up at week 13.
Home Care:n/a

Hide details for Study Contact InformationStudy Contact Information

Physician Name:Michael Wang
For Clinical Trial Enrollment:713-792-2860
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)

Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults